Alcohol may contribute to your Uncomfortable side effects and interfere with the discharge of Concerta tablets. Avoid.
Din läkare more info kan ge mer data om denna hazard. Tala om fileör läkare eller apotekspersonal innan Concerta används om du eller din dotter är:
A replica examine in rats discovered no proof of damage to your fetus at oral doses as many as thirty mg/kg/working day, somewhere around fifteen-fold and three-fold the utmost proposed human dose of CONCERTA® on the mg/kg and mg/m2 foundation, respectively.
unique etiology of this syndrome is not known, and there's no one diagnostic examination. sufficient prognosis needs using healthcare and special psychological, instructional, and social assets.
may possibly have an effect on blood circulation within the palms and feet. signs and symptoms may increase after a dosage reduction or discontinuation.
beneath rubriken ”Bilder och delbarhet” kan läkemedelsföretagen publicera fotografier av tabletter och kapslar samt bilder av medicintekniska hjälpmedel som används för att tillföra läkemedlet till kroppen (tex en penna fileör injektion eller en inhalator).
har ett psykiskt trouble som inte nämns i ovanstående avsnitt ”Ta inte Concerta om du eller ditt barn”. Andra psykiska problem kan vara:
Om du eller ditt barn tar andra läkemedel kan metylfenidat påverka hur bra dessa fungerar eller orsaka biverkningar. Om du eller ditt barn tar nåreceived av följande läkemedel måste ni rådgöra med läkaren eller apotekspersonal innan ni tar Concerta:
Om du har ytterligare frågor om användningen av detta läkemedel kontakta läkare eller apotekspersonal.
This part contains adverse reactions described by CONCERTA-taken care of topics in double-blind trials that do not fulfill the standards specified for desk four or Table five and all adverse reactions noted by CONCERTA-taken care of topics who participated in open-label and postmarketing medical trials.
Because the CONCERTA® tablet is nondeformable and doesn't appreciably change in shape inside the GI tract, CONCERTA® mustn't ordinarily be administered to sufferers with preexisting critical gastrointestinal narrowing (pathologic or iatrogenic, for example: esophageal motility Conditions, tiny bowel inflammatory disorder, "small gut" syndrome resulting from adhesions or decreased transit time, earlier heritage of peritonitis, cystic fibrosis, Persistent intestinal pseudoobstruction, or Meckel's diverticulum).
Läs upp Gå till mobil.fass.se Nu gör vi om Fass. Läs mer här. Ordförklaringar Textstorlek
Renal Insufficiency there's no experience with using CONCERTA® in clients with renal insufficiency. just after oral administration of radiolabeled methylphenidate in human beings, methylphenidate was extensively metabolized and close to 80% with the radioactivity was excreted in the urine in the form of PPAA.
In human beings, methylphenidate is metabolized principally by de-esterification to PPAA, which has little or no pharmacologic exercise. In Older people the metabolism of CONCERTA® once day-to-day as evaluated by metabolism to PPAA is comparable to that of methylphenidate thrice day-to-day.